PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.73%104.101.1%$1332.57m
GILDGilead Sciences, Inc.
0.04%72.440.9%$675.30m
AMGNAmgen Inc.
-0.45%170.001.1%$499.55m
BIIBBiogen Inc.
0.00%313.971.2%$468.09m
REGNRegeneron Pharmaceuticals, Inc.
-0.79%391.592.7%$363.74m
ALXNAlexion Pharmaceuticals, Inc.
0.49%110.871.9%$288.55m
VRTXVertex Pharmaceuticals Incorporated
-0.36%147.411.9%$237.28m
INCYIncyte Corporation
-0.95%105.472.5%$187.59m
ALNYAlnylam Pharmaceuticals, Inc
0.89%127.5110.6%$184.43m
ILMNIllumina, Inc.
0.25%209.023.5%$165.18m
NKTRNektar Therapeutics
0.13%44.996.1%$146.11m
JUNOJuno Therapeutics, Inc.
1.56%58.6413.5%$138.44m
BMRNBioMarin Pharmaceutical Inc.
0.39%82.884.4%$117.68m
SRPTSarepta Therapeutics, Inc.
1.94%56.1116.8%$117.17m
BLUEBluebird Bio, Inc.
1.90%163.2017.2%$116.94m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.